Premium
RELAPSES IN INTERIM PET NEGATIVE LIMITED STAGE HODGKIN LYMPHOMA PATIENTS RECEIVING ABVD WITH OR WITHOUT RADIOTHERAPY–ANALYSIS OF EORTC/FIL/LYSA H10 AND UK NCRI RAPID TRIALS
Author(s) -
Aurer I.,
Neven A.,
Fiaccadori V.,
Counsell N.,
Phillips E.,
CliftonHadley L.,
Fortpied C.,
Andre M.,
Federico M.,
Barrington S.,
Illidge T.,
Radford J.,
Raemaekers J.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.71_2879
Subject(s) - medicine , abvd , hazard ratio , interim analysis , radiation therapy , stage (stratigraphy) , confidence interval , interim , proportional hazards model , procarbazine , hodgkin lymphoma , oncology , lymphoma , chemotherapy , randomized controlled trial , vincristine , cyclophosphamide , history , paleontology , archaeology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom